The Psychology of GLP-1 Receptor Agonists: Evidence for Distinct Effects on Reward, Interoception and Cognition
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely used for obesity and type 2 diabetes, supporting weight loss and glycaemic control through effects on appetite and ingestive behaviour. The psychobiological mechanisms underlying these effects remain unclear. We reviewed evidence for candidate mechanisms and analysed quantitative and qualitative self-reported changes in appetite-related experiences from 704 people using GLP-1 RAs. Participants reported multiple changes that appeared distinct for food versus alcohol, with reductions in food urges and cravings largely independent of changes in alcohol use. Enhanced awareness and utilisation of hunger and satiety signals were frequently described, suggesting potential changes in interoceptive processes. Changes in enjoyment of eating were largely independent of reductions in food cravings, urges to eat, and gastrointestinal side effects. Improved ability to eat in a goal-directed manner was also frequently reported. Results support the presence of multiple cognitive and behavioural processes contributing to reduced food intake and provide testable hypotheses to explore in experimental work designed to isolate effects of GLP-1 RAs on goal-directed control, interoceptive awareness, attention, memory, and executive function.
Related
- Availability of age-stratified evidence for GLP1 receptor agonists and SGLT2 inhibitors: an analysis of European public assessment reports with a focus on older patients
- Glucagon-like peptide-1 receptor agonists beyond weight loss: A paradigm shift in cardiovascular prevention
- Divergent ocular safety profiles of glucagon-like peptide-1 receptor agonists: a pharmacological heterogeneity framework
- Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
- Glucagon-Like Peptide-1 Receptor Agonists and the Eye: Ocular Safety, Retinal Outcomes, and Clinical Implications
BibTeX
@misc{watson2026psychology,
title = {{The Psychology of GLP-1 Receptor Agonists: Evidence for Distinct Effects on Reward, Interoception and Cognition}},
author = {Poppy Watson and Simone Rehn and Mike Kendig and Dominic Tran and Justin Mahlberg and Kristi Griffiths},
howpublished = {PsyArXiv},
year = {2026},
month = oct,
doi = {10.31234/osf.io/vhrka_v2},
url = {https://osf.io/preprints/psyarxiv/vhrka_v2/},
note = {CC BY 4.0},
}
RIS
TY - UNPB
TI - The Psychology of GLP-1 Receptor Agonists: Evidence for Distinct Effects on Reward, Interoception and Cognition
AU - Poppy Watson
AU - Simone Rehn
AU - Mike Kendig
AU - Dominic Tran
AU - Justin Mahlberg
AU - Kristi Griffiths
PY - 2026
DA - 2026/10/14
PB - PsyArXiv
DO - 10.31234/osf.io/vhrka_v2
UR - https://osf.io/preprints/psyarxiv/vhrka_v2/
AB - Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely used for obesity and type 2 diabetes, supporting weight loss and glycaemic control through effects on appetite and ingestive behaviour. The psychobiological mechanisms underlying these effects remain unclear. We reviewed evidence for candidate mechanisms and analysed quantitative and qualitative self-reported changes in appetite-related experiences from 704 people using GLP-1 RAs. Participants reported multiple changes that appeared distinct for food versus alcohol, with reductions in food urges and cravings largely independent of changes in alcohol use. Enhanced awareness and utilisation of hunger and satiety signals were frequently described, suggesting potential changes in interoceptive processes. Changes in enjoyment of eating were largely independent of reductions in food cravings, urges to eat, and gastrointestinal side effects. Improved ability to eat in a goal-directed manner was also frequently reported. Results support the presence of multiple cognitive and behavioural processes contributing to reduced food intake and provide testable hypotheses to explore in experimental work designed to isolate effects of GLP-1 RAs on goal-directed control, interoceptive awareness, attention, memory, and executive function.
ER -